Search Within

Jason Konner

Formats
  1. Journal Article (83)
  2. Meeting Abstract (69)
  3. Correspondence (2)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (156)
  2. GDMT, Medicine (156)
  3. Gynecologic Medicine Service (156)
  4. Gynecology Disease Management Team (156)
  5. Solid Tumor Oncology Division (156)
  6. Surgery (59)

More Groups

People
  1. Carol Aghajanian (85)
  2. William Tew (60)
  3. Paul Sabbatini (52)
  4. Martee Hensley (49)
  5. Alexia Iasonos (44)
  6. Roisin O'Cearbhaill (43)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (8)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Gynecologic Oncology (31)
  3. International Journal of Gynecological Cancer (14)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (9)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Elsevier Inc. (35)
  3. American Association for Cancer Research (15)
  4. Lippincott Williams & Wilkins (15)
  5. Oxford University Press (11)
  6. Springer (6)

More Publishers

Results (156)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
    Journal Article

    Martin, L. P.; Konner, J. A.; Moore, K. N.; Seward, S. M.; Matulonis, U. A.; Perez, R. P.; Su, Y.; Berkenblit, A.; Ruiz-Soto, R.; Birrer, M. J.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Berman, B.; Konner, J.; Belum, V. R.; Dion, H.; Ciccolini, K.; Kitts, S.; Ye, R.; Ravipaty, S.; Akmaev, V. R.; Sarangarajan, R.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
    Journal Article

    Jiménez-Sánchez, A.; Memon, D.; Pourpe, S.; Veeraraghavan, H.; Li, Y.; Vargas, H. A.; Gill, M. B.; Park, K. J.; Zivanovic, O.; Konner, J.; more...
    Cell (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Goldfarb, S. B.; Konner, J.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Safety and activity of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A phase I expansion study
    Journal Article

    Moore, K. N.; Martin, L. P.; O'Malley, D. M.; Matulonis, U. A.; Konner, J. A.; Perez, R. P.; Bauer, T. M.; Ruiz-Soto, R.; Birrer, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • IMGN853 (mirvetuximab soravtansine), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC): Single-agent activity in platinum resistant epithelial ovarian cancer (EOC) patients (pts)
    Meeting Abstract

    Moore, K. N.; Martin, L. P.; Matulonis, U. A.; Konner, J. A.; Seward, S. M.; Bauer, T. M.; O'Malley, D. M.; Perez, R. P.; Jeong, W. D.; Zhou, Y. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study
    Meeting Abstract

    Lacouture, M. E.; Konner, J. A.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations
    Journal Article

    Shu, C. A.; Pike, M. C.; Jotwani, A. R.; Friebel, T. M.; Soslow, R. A.; Levine, D. A.; Nathanson, K. L.; Konner, J. A.; Arnold, A. G.; Bogomolniy, F.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • A phase 2, single arm study of iniparib in patients with BRCA1 or BRCA2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Journal Article

    Bell-McGuinn, K. M.; Konner, J. A.; Tew, W. P.; Hensley, M. L.; Iasonos, A.; Charpentier, E.; Mironov, S.; Sabbatini, P.; Aghajanian, C.
    International Journal of Gynecological Cancer (2016)

    Fulltext@MSK | Save